<prompt> Answer this question truthfullyHow cost-effective is therapy for Galactosemia?  <response>: <reason> The screening cost of galactosemia is less than the benefits i.e. QALYs achieved through screening, thereby making its implementation cost-effective . Moreover, decreasing the false-positives , using healthcare information systems and economical diagnostic techniques, establishing a centralized laboratory and combining with other screening programs will help in further reducing the financial burden. The efficiency of the neonatal screening policy is also inversely related to the prevailing interest rate in the economy . 